Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure |
---|---|
6/30/2025 | $ 517K |
3/31/2025 | $ 680K |
12/31/2024 | $ 464K |
9/30/2024 | $ 445K |
6/30/2024 | $ 581K |
3/31/2024 | $ 1.18M |
12/31/2023 | $ 2.69M |
9/30/2023 | $ 7.24M |
6/30/2023 | $ 9.84M |
3/31/2023 | $ 16.08M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Sep 30, 2024
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.92K |
---|---|
min | $ -41.06M |
max | $ 63.78M |
average | $ 9.66M |
median | $ 1.92M |
std | $ 15.86M |